| Tag | Content |
|---|
EnhancerAtlas ID | HS059-27369 |
Organism | Homo sapiens |
Tissue/cell | GM12878 |
Coordinate | chr2:204538420-204539430 |
| | Number of super-enhancer constituents: 7 | ID | Coordinate | Tissue/cell |
| SE_36108 | chr2:204538565-204539935 | HMEC | | SE_37117 | chr2:204537734-204541505 | HSMMtube | | SE_43536 | chr2:204537286-204540324 | MM1S | | SE_45924 | chr2:204538361-204540698 | Osteoblasts | | SE_51863 | chr2:204538612-204540723 | Skeletal_Muscle_Myoblast | | SE_63659 | chr2:204538568-204540723 | HSMM | | SE_66393 | chr2:204538541-204539632 | Jurkat |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I203673 | chr2 | 204538425 | 204540552 |
|
Enhancer Sequence | GTCCTATGTC TACTTTTAGC CAATATTTGT GAGCATCAAC CATATCCCTC CTCAGTAATT 60
ATATTTTATT TTTTCCTCCC AGGTCATGTG AAAGACTGTG TATAATTCAG AAGAGATATT 120
TCTACAGTGA AAAAAAATAC CCCATATTTA AATCAATTCA AGTTTCTTCT TGACATCTAG 180
GCTGTATCTA GGACACATCT GGACATCTGG AAACATCCAA ATTTGACTGA CTTTTCCAGT 240
TTTCAGCAGA ACATTTAGTA AATAAAAGAA TAAGAAACTT GTACTAATCA TATATTTTTT 300
TGAAAGTCAA CAGCATTTCA GTGGGGCTGA TGTCCTCATG GCCTGGCCTT TATTTCTTGC 360
CTCATGTCAG ACTTAACCCA TGTTGGTGGA GGAGGCTGAC ATTCAAAGGG TGTGGTTTTT 420
GAGGTTGCCA CATGCCTTGC CATGACTTAA AATATCTCTC TCTGGCTGCC AGATGGCCTG 480
GGGAAGCACC AGACACAGGC TCCATTGACC TCAGAACTTG TTGCTTTAGG ACTGGAAGCT 540
CTTTCAGGGT CTTTCTTAAA TTTCTGTTTC TAAATATCTG AAGCACATCA AGCCTTAAAC 600
TGGGGTTTTG TGCTGCTCCT CCTCGCTTTC CTGAAAGCAA AGGGTAAGAA TTAATTTCGG 660
GCACAGATAG TAAATGCTGA CTTTTCATTG TTCCCTTGAG AACACTTCAC TCTCCAAGAG 720
AAAGTCTCCC TTCTTCAGCC CAAATCTTGT GGAAACTGTG CATATGAGGT GTGGAGAAAC 780
CCCATGGGAA AACTGGGAGT CTACAAACAG GCCTAGTCTT TGAGGATGCT CGGCAGGGGT 840
GGAGGAAGAC GCCTCAGGTA TCTCTTCAGG TCCAATTCCC TACTGGATGT AGATATACAA 900
AATGTAATTT ACTTCCAGTT ATTGAATGAT AATGTCTTGA AACATTAGAA AAATAGTCAT 960
CTTGAAGGAA AAGGCAAAGA AGATTATTTG GAGAGGAGAA GTTTTTTTTC 1010
|
